{
  "total_samples": 1,
  "topics": {
    "Cancer Immunotherapy (PD-1/PD-L1 inhibitors; CTLA-4 combination; tumor microenvironment biomarker)": 1
  },
  "question_types": {
    "efficacy_comparison": 1
  },
  "avg_tool_calls": 5.0,
  "avg_content_rubrics": 4.0,
  "generation_time": "2025-12-16T14:43:25.727323"
}